Comparing the Clinical Trial Characteristics of Industry-Funded Trials and Non Industry-Funded Trials

被引：0

作者：

Hughes, Emily ^{[1
]}

Van Bakel, Tamara ^{[2
]}

Raudanskis, Ashley ^{[1
]}

Ray, Prachi ^{[1
]}

Hodzic-Santor, Benazir ^{[1
]}

Purohit, Ushma ^{[1
]}

Sacks, Chana A. ^{[3
,4
]}

Fralick, Michael ^{[1
,2
]}

机构：

[1] Sinai Hlth Syst, Div Gen Internal Med, Toronto, ON, Canada

[2] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada

[3] Harvard Med Sch, Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA USA

[4] Harvard Med Sch, Massachusetts Gen Hosp, Mongan Inst, Boston, MA USA

来源：

JOURNAL OF LAW MEDICINE & ETHICS | 2024年 / 52卷 / 03期

关键词：

Randomized Controlled Trials; Funder; Trial Characteristics; Pharmaceutical; Industry; Natural Language Processing;

D O I：

10.1017/jme.2024.135

中图分类号：

B82 [伦理学（道德学）];

学科分类号：

摘要：

We compared study characteristics of randomized controlled trials funded by industry (N=697) to those not funded by industry (N=835). RCTs published in high-impact journals are more likely to be blinded, more likely to include a placebo, and more likely to post trial results on ClinicalTrials.gov. Our findings emphasize the importance of evaluating the quality of an RCT based on its methodological rigor, not its funder type.

引用

页码：693 / 700

页数：8

共 28 条

[21] Ongoing non-industry-sponsored COVID-19 clinical trials in the first trimester of the pandemic: significant differences between the European and the USA approaches
Dal-Re, Rafael
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (09) : 1067 - 1072
[22] A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design
Goswami, Neela D.
Tsalik, Ephraim L.
Naggie, Susanna
Miller, William C.
Horton, John R.
Pfeiffer, Christopher D.
Hicks, Charles B.
TRIALS, 2014, 15
[23] A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design
Neela D Goswami
Ephraim L Tsalik
Susanna Naggie
William C Miller
John R Horton
Christopher D Pfeiffer
Charles B Hicks
Trials, 15
[24] The role of corruption and unethical behaviour in precluding the placement of industry sponsored clinical trials in sub-Saharan Africa: Stakeholder views
Egharevba, Efe
Atkinson, Jacqueline
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2016, 3 : 102 - 110
[25] Association between industry support and the reporting of study outcomes in randomized clinical trials of dental implant research from the past 20 years
Dini, Caroline
Alves Pereira, Marta Maria
Silva Souza, Joao Gabriel
Shibli, Jamil A.
Avila, Erica Dorigatti
Barao, Valentim Adelino R.
CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, 2022, 24 (01) : 94 - 104
[26] Trends of Informed Consent forms for industry-sponsored clinical trials in rheumatology over a 17-year period: Readability, and assessment of patients' health literacy and perceptions
de la Mora-Molina, Hector
Barajas-Ochoa, Aldo
Sandoval-Garcia, Leon
Navarrete-Lorenzon, Martha
Castaneda-Barragan, Edgar A.
Dionisio Castillo-Ortiz, Jose
Javier Aceves-Avila, Francisco
Yanez, Jose
Patricia Bustamante-Montes, Lilia
Ramos-Remus, Cesar
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (03) : 547 - 552
[27] Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials
Sajesh K. Veettil
Kean Ghee Lim
Siew Mooi Ching
Surasak Saokaew
Pochamana Phisalprapa
Nathorn Chaiyakunapruk
BMC Cancer, 17
[28] Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials
Veettil, Sajesh K.
Lim, Kean Ghee
Ching, Siew Mooi
Saokaew, Surasak
Phisalprapa, Pochamana
Chaiyakunapruk, Nathorn
BMC CANCER, 2017, 17

← 1 2 3 →